Cite
HARVARD Citation
Dong, G. et al. (2023). Recent updates on 1, 2, 3‐, 1, 2, 4‐, and 1, 3, 5‐triazine hybrids (2017–present): The anticancer activity, structure–activity relationships, and mechanisms of action. Archiv der Pharmazie. 356 (3), p. n/a. [Online].